Buyer's Guide

Contact | Print version | PDF version | Recommend company

Portrait
CellGenix develops, manufactures and markets cell and protein therapeutics for tumor and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing.

The company owns Metreon Bioproducts GmbH, which was founded in 1996 as a joint venture together with Schering AG. CellGenix also owns shares in American Fluoroseal Cooperation (Afc) in Gaithersburg, Maryland (USA), and in CellPrep S.A. in Buenos Aires (Argentina).

CellGenix's research focuses on stem cell therapy for the regeneration of tissues and organs, tumor immunotherapy, and drug targeting, a highly selective cell-specific patient specific therapy, for cancer.

CellGenix's extensive experience with GMP manufacturing and applications of cell therapeutics has enabled the company to build up a strategically significant portfolio of intangible assets and trade secrets in the field of GMP production of cell and protein therapeutics

Industrial Sectors

Pharmacy